[1]
D. Z. Sapitri, F. Mareta, and D. Anggraini, “Corporate Governance, Profitability, and Financial Statement Fraud Risk in Indonesian Pharmaceutical Companies”, JR, vol. 10, no. 4, pp. 879–895, Aug. 2026.